AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing ...

AbbVie (NYSE: ABBV) shares lost ground Friday. The company announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

New, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and ...

For years, the healthcare industry has been a cornerstone of the economy, offering resilience in both stable and uncertain ...

This Elliott Wave analysis for AbbVie Inc. (ABBV), breaks down the stock’s current price action using Elliott Wave Theory, providing traders with insights into possible opportunities. We’ll explore ...

More than 39 million people around the world could die from antibiotic-resistant infections over the next 25 years, according to a study published in The Lancet.  The new study by the Global Research ...

AbbVie’s attempts to diversify beyond Humira have been boosted as its investigational drug upadacitinib has been granted Priority Review by the FDA for moderate to severe rheumatoid arthritis (RA).

With the help of the Spokane County dive team, the body of the 72-year-old Reiner was recovered from the roughly 95-acre lake ...

Safety Assessment Program has published peer-reviewed safety assessments covering over 2,000 fragrance materials in the peer-reviewed ...

AbbVie and Anima Biotech have announced that ... it is in the latter stages of FDA review. AstraZeneca has revealed the data for Imfinzi in muscle-invasive bladder cancer (MIBC) that it hopes ...

But the healthcare system in the US still struggles to provide adequate care for those with serious mental illness ...